Not Yet RecruitingNot Applicable

Clinical Outcomes of Primary Versus Secondary Antiphospholipid Syndrome

Egypt52 participantsStarted 2025-02-07

Plain-language summary

Observational retrospective cohort study to assess clinical outcomes in patients with primary versus secondary antiphospholipid syndrome

Who can participate

Age range18 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients diagnosed as antiphospholipid syndrome in clinical hematology or rheumatology units in internal medicine department, Assiut university hospital. Exclusion Criteria: * patients with other risk factor for thrombosis (malignancy, cocs, protein c or protein s deficiency etc

What they're measuring

to compare percentage of patients with primary versus secondary antiphospholipid syndrome in developing recurrent thrombosis

Timeframe: 12 months

Trial details

NCT IDNCT06808607

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-03-06

Contact for this trial

Maha Abdel-Aziz, Clinical Hematology MD

2001097278659 maha.hematology@aun.edu.eg

View on ClinicalTrials.gov More Antiphospholipid Syndrome trials